Current status and future prospects of nanoneurology

Journal of Nanoneuroscience

Volumn 1, Issue 1, 2009, Pages 56-64

  Jain, K K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

Blood Brain barrier; Nanobiotechnology; Nanofibers; Nanoneurology; Nanoneurosciences; Nanoneurosurgery; Nanoneurotherapeutics; Nanoparticles; Neurooncology; Quantum dots

Indexed keywords

ANTIOXIDANT; MOLECULAR SCAFFOLD; NANOFIBER; NANOPARTICLE; NANOTUBE; NANOWIRE; QUANTUM DOT;

BLOOD BRAIN BARRIER; BRAIN INJURY; BRAIN TUMOR; DIAGNOSTIC PROCEDURE; DRUG DELIVERY SYSTEM; DRUG SAFETY; GLIOBLASTOMA; HUMAN; IMPLANT; NANOBIOTECHNOLOGY; NEUROLOGIC DISEASE; NEUROLOGY; NEUROPROTECTION; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEOMICS; REVIEW; ROBOTICS;

EID: 67649970082     PISSN: 19390637     EISSN: 19390653     Source Type: Journal    
DOI: 10.1166/jns.2009.006     Document Type: Review

References (37)

1. Aliautdin RN, Kreuter J, Kharkevich DA (2003) Drug delivery to the brain with nanoparticles. Eksp Klin Farmakol 66:65-8.
2. Anderson EA, Isaacman S, Peabody DS, Wang EY, Canary JW, Kirshenbaum K (2006) Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Lett 6:1160-1164.
3. Callera F, de Melo C (2007) Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells' migration into the injured site. Stem Cells and Development 16:461-466.
4. Costantino L, Gandolfi F, Tosi G, Rivasi F, Vandelli MA, Forni F (2005) Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. J Control Release 108:84-96.
5. Ellis-Behnke RG, Teather LA, Schneider GE, So KF (2007) Using nanotechnology to design potential therapies for CNS regeneration. Curr Pharm Des 13:2519-28.
6. Ellis-Behnke RG, Liang YX, You SW, Tay DK, Zhang S, So KF, Schneider GE (2006) Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA 103:5054-9.
7. Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, Stellwagen D, Capela A, Greve J, Malenka RC, Moseley ME, Palmer TD, Steinberg GK (2007) Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci USA 104:10211-6.
8. Jain KK (2006) Role of nanotechnology in developing new therapies for diseases of the nervous system (editorial). Nanomedicine 1:9-12.
9. Jain KK (2007) Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert Rev Neurother 7:363-372.
10. Jain KK (2007a) Applications of nanobiotechnology in clinical diagnostics. Clin Chem 53:2002-2009.
11. Jain KK (2007b) Role of nanobiotechnology in drug discovery. Pharmaceutical Biotechnology (Guzman CA, Feuerstein G, eds). Landes Press, http://eurekah.com/chapter/3570.
12. Jain KK (2007c) Nanobiotechnology-based drug delivery to the central nervous system. Neurode generative Dis 4:287-291.
13. Jain KK (2008) Handbook of Nanomedicine. Humana/Springer, Tatowa, NJ.
14. Kam NW, Dai H (2005) Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc 127:6021-6.
15. Kattumuri V, Katti K, Bhaskaran S, Boote EJ, Casteel SW, Fent GM, Robertson DJ, Chandrasekhar M, Kannan R, Katti KV (2007) Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies. Small 3:333-341.
16. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Research 63:8122-8125.
17. Kransnoslobodtsev AV, Shlyakhtenko LS, Ukraintsev E, Zaikova TO, Keana JF, Lyubchenko YL (2005) Nanomedicine and protein misfolding diseases. Nanomedicine 1:300-305.
18. Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R (2002) Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 10:317-25.
19. Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B, Alyautdin R, von Briesen H, Begley DJ (2003) Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res 20:409-16.
20. Li J, Andrews RJ (2007) Trimodal nanoelectrode array for precise deep brain stimulation: prospects of a new technology based on carbon nanofiber arrays. Acta Neurochir Suppl 97:537-45.
21. Liopo AV, Stewart MP, Hudson J, Tour JM, Pappas TC (2006) Biocompatibility of native and functionalized single-walled carbon nanotubes for neuronal interface. J Nanosci Nanotechnol 6:1365-1374.
22. Llinas RR, Walton KD, Nakao M, Hunter I, Anquetil PA (2005) Neurovascular central nervous recording/stimulating system: using nanotechnology probes. J Nanoparticle Res 7:111-127.
23. McKenzie JL, Waid MC, Shi R, Webster TJ (2004) Decreased functions of astrocytes on carbon nanofiber materials. Biomaterials 25:1309-17.
24. Michaelis K, Hoffmann MM, Dreis S, Herbert E, Alyautdin RN, Michaelis M, Kreuter J, Langer K (2006) Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 317:1246-53.
25. Pappas TC, Wickramanyake WM, Jan E, Motamedi M, Brodwick M, Kotov NA (2007) Nanoscale engineering of a cellular interface with semiconductor nanoparticle films for photoelectric stimulation of neurons. Nano Lett 7:513-519.
26. Peters A, Veronesi B, Calderón-Garcidueñas L, Gehr P, Chen LC, Geiser M, Reed W, Rothen-Rutishauser B, Schürch S, Schulz H (2006) Translocation and potential neurological effects of fine and ultrafine particles: a critical update. P article and Fibre Toxicology 3:13.
27. Petry KG, Boiziau C, Dousset V, Brochet B (2007) Magnetic resonance imaging of human brain macrophage infiltration. Neurotherapeutics 4:434-42.
28. Rzigalinski BA, Meehan K, Davis RM, Xu Y, Miles WC, Cohen CA (2006) Radical nanomedicine. Nanomedicine 1:399-412.
29. Sayes CM, Liang F, Hudson JL, Mendez J, Guo W, Beach JM, Moore VC, Doyle CD, West JL, Billups WE, Ausman KD, Colvin VL (2006) Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. T oxicol Lett 161:135-42.
30. Schubert D, Dargusch R, Raitano J, Chan S (2006) Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 342:86-91.
31. Sharma HS (2007) Nanoneuroscience: emerging concepts on nanoneurotoxicity and nanoneuroprotection. Nanomed 2:753-8.
32. Silva GA (2005) Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system. Sur g Neurol 63:301-6.
33. Stieglitz T (2007) Restoration of neurological functions by neuroprosthetic technologies: future prospects and trends towards micro-, nano-, and biohybrid systems. Acta Neurochir Suppl 97:435-42.
34. Sykova E, Jendelova P (2007) In vivo tracking of stem cells in brain and spinal cord injury. Prog Brain Res 161C:367-383.
35. Thorne RG, Nicholson C (2006) In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc Natl Acad Sci USA 103:5567-72.
36. Tiwari SB, Amiji MM (2006) A review of nanocarrier-based CNS delivery systems. Curr Drug Deliv 3:219-32.
37. Yanik MF, Cinar H, Cinar HN, Chisholm AD, Jin Y, Ben-Yakar A (2004) Neurosurgery: functional regeneration after laser axotomy. Nature 432:822.